Literature DB >> 30997922

Age of HIV Acquisition Affects the Risk of Multi-Morbidity after 25 Years of Infection Exposure.

G Guaraldi1, A Malagoli, J Milic, I Pintassilgo, E Rossi, N Riva, I Franconi, A Santoro, P Sorin, A Streinu-Cercel, M De Rosa, C Mussini.   

Abstract

INTRODUCTION: Understanding the intersection of HIV, aging and health is crucial due to the increasing number of people aging with HIV.
OBJECTIVE: The objective of the study was to assess the prevalence of, and risk factors for individual comorbidities and multi-morbidity in people living with HIV with similar duration of HIV infection, notwithstanding a 25-year difference at the time of HIV acquisition.
METHODS: In a cross-sectional multicentre retrospective study, we compared three match-control age groups. The "Young" were selected from Romania and included HIV-positive patients prenatally infected and assessed at the age of 25-30 years. The "Old" and the "Geriatric" were selected from Italy. These respectively included subjects infected with HIV at the age of 25 years and assessed at the age of 50-55 years, and those infected at the age of 50 years and assessed at the age of 75-80 years. Each group was sex and age matched in a 1:5 ratio with controls selected from the CINECA ARNO database from Italy. We described non-infectious comorbidities (NICM), including cardiovascular disease, hypertension, dyslipidaemia, diabetes, chronic kidney disease, and multi-morbidity (MM≥ 3 NICM).
RESULTS: MM prevalence in the "Young" group compared to controls was 6.2% vs 0%, while in the "Geriatric" was "68.2% vs 3.6%. Using "Young" as a reference, in multivariate analyses, predictors for MM were as follows: HIV serostatus (OR=47.75, IQR 14.78-154.25, p<0.01) and "Geriatric" vs "Young" (OR=30.32, IQR 5.89-155.98, p<0.01).
CONCLUSION: These data suggest that age at acquisition of HIV should be considered as a risk factor for NICM and MM.

Entities:  

Keywords:  HIV; acquisition; age; multi-morbidity

Mesh:

Year:  2019        PMID: 30997922     DOI: 10.14283/jfa.2019.6

Source DB:  PubMed          Journal:  J Frailty Aging        ISSN: 2260-1341


  3 in total

1.  Tenofovir disoproxil fumarate induces peripheral neuropathy and alters inflammation and mitochondrial biogenesis in the brains of mice.

Authors:  Jerel Adam Fields; Mary K Swinton; Aliyah Carson; Benchawanna Soontornniyomkij; Charmaine Lindsay; May Madi Han; Katie Frizzi; Shrey Sambhwani; Anne Murphy; Cristian L Achim; Ronald J Ellis; Nigel A Calcutt
Journal:  Sci Rep       Date:  2019-11-20       Impact factor: 4.379

2.  Prevalence of low high-density lipoprotein among young adults receiving antiretroviral therapy in Zambia: An opportunity to consider non-communicable diseases in resource-limited settings.

Authors:  Benson M Hamooya; Patrick Musonda; Wilbroad Mutale; Sepiso K Masenga; Hikabasa Halwiindi; Katongo H Mutengo; Kaseya O R Chiyeñu; Gershom Chongwe; John R Koethe; Loren Lipworth; Douglas C Heimburger
Journal:  PLoS One       Date:  2021-02-16       Impact factor: 3.240

3.  Immune activation and chronic inflammation: Is there an additional effect of HIV in a geriatric population?

Authors:  Delphine Sauce; Valérie Pourcher; Tristan Ferry; Jacques Boddaert; Laurence Slama; Clotilde Allavena
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.